NCT00166868View on ClinicalTrials.gov

Use of Probiotics to Prevent Cholangitis in Children With Biliary Atresia After the Kasai Portoenterostomy

NACompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

December 31, 2003

Primary Completion Date

January 31, 2012

Study Completion Date

July 31, 2012

Conditions
Biliary Atresia
Interventions
DRUG

Lactobacillus casei rhamnosus (Lcr35)

DRUG

Neomycin

Trial Locations (1)

Unknown

National Taiwan University Hospital, Taipei

All Listed Sponsors
lead

National Taiwan University Hospital

OTHER

NCT00166868 - Use of Probiotics to Prevent Cholangitis in Children With Biliary Atresia After the Kasai Portoenterostomy | Biotech Hunter | Biotech Hunter